Oops, you're using an old version of your browser so some of the features on this page may not be displaying properly.

MINIMAL Requirements: Google Chrome 24+, Mozilla Firefox 20+, Internet Explorer 11, Opera 15–18, Apple Safari 7, SeaMonkey 2.15-2.23

Become a member
  1. OncologyPRO
  2. Meeting Resources

ESMO Breast Cancer 2023

11 - 13 May 2023

Berlin, Germany

ESMO-Breast-Cancer-2023-1000x1000

Resources from ESMO Breast Cancer 2023 are available according to the presenters' agreement to release them.

Abstracts and ePosters are open access.
Slides and webcasts are reserved to ESMO Members and registered delegates.

The copyright protected educational resources from this event are for personal usage only and not to be shared with any third parties. ESMO thanks the authors for their generosity.

Meeting programme Next/upcoming meetings

The ESMO Breast Cancer Congress is a multidisciplinary meeting with a global scope, involving top scientists. This annual meeting is designed for researchers and clinicians who have a specific interest in innovation (including translational research, new agents, molecular and functional diagnostics, biomarkers and cutting-edge research applications in the clinical setting) and patient's care.

Watch the webcasts from our industry partners satellite symposia

All congress resources are published
Type an abstract number in the search, or use the filters to refine the list!

Hide
Filter by:
Search:
Reset

There are 413 resources available

Welcome and introductions

Presenter: Andreas Schneeweiss

Session: Seagen - Case by case: How to optimize HER2+ metastatic breast cancer (MBC) treatment in second line and beyond

Resources:

Webcast

Introduction

Presenter: Sibylle Loibl

Session: F. Hoffmann-La Roche - PI3King the right treatment for every patient with HR+ breast cancer

Resources:

Webcast

Evolving treatment landscape

Presenter: Andreas Schneeweiss

Session: Seagen - Case by case: How to optimize HER2+ metastatic breast cancer (MBC) treatment in second line and beyond

Resources:

Webcast

Q&A / discussion

Presenter: To be Announced

Session: F. Hoffmann-La Roche - PI3King the right treatment for every patient with HR+ breast cancer

Resources:

Webcast

Q&A / Key takeaways

Presenter: To be Announced

Session: Seagen - Case by case: How to optimize HER2+ metastatic breast cancer (MBC) treatment in second line and beyond

Resources:

Webcast

This site uses cookies. Some of these cookies are essential, while others help us improve your experience by providing insights into how the site is being used.

For more detailed information on the cookies we use, please check our Privacy Policy.

Customise settings

  • Necessary cookies enable core functionality. The website cannot function properly without these cookies, and you can only disable them by changing your browser preferences.